LONDON - Days after carving out its consumer health business, a slimmed down GSK delivered a strong second-quarter ...
LONDON (Reuters) -GSK raised its 2025 sales and earnings forecasts on Wednesday as its speciality HIV and cancer drugs posted double digit growth, lifting the British company's shares by nearly 7% to ...
GSK has received the Food and Drug Administration’s approval for a prefilled syringe presentation of Shingrix (GSK’s Recombinant Zoster Vaccine or RZV) for the prevention of shingles (herpes zoster).
By Bhanvi Satija LONDON, April 29 (Reuters) - Strong first-quarter results under new GSK CEO Luke Miels on Wednesday failed to impress investors, who raised concerns that the British drugmaker's ...
Trial met primary endpoint, non-inferior immune response for both vaccines when co-administered compared with separate administration Co-administration of the RSV and shingles adjuvanted vaccines was ...
GSK raised its full-year financial outlook despite mixed results from its vaccines segment and declining sales of Shingrix. The British pharma giant reported total quarterly sales of £7.9 billion, up ...
Dynavax Technologies Corporation (NASDAQ:DVAX) announced topline results from Part 1 of its randomized, observer-blinded, and active-controlled Phase 1/2 clinical trial of Z-1018, a shingles vaccine ...
(RTTNews) - British drug maker GSK plc (GSK, GSK.L) announced Friday that the US Food and Drug Administration has accepted for review the regulatory application of a prefilled syringe presentation of ...
Zacks Investment Research on MSN
GSK stock declines 9% in a month: Time to buy, hold or exit?
GSK GSK shares have lost 8.8% in a month, mainly because investors were disappointed with the company maintaining guidance ...
(RTTNews) - British drug major GSK plc (GSK, GSK.L) announced Thursday that the US Food and Drug Administration has approved a prefilled syringe presentation of Shingrix, GSK's Recombinant Zoster ...
Please provide your email address to receive an email when new articles are posted on . The original formulation of Shingrix consists of two separate vials combined by health care workers prior to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results